---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-074568"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2023-09-07T23:59:59+00:00"
generated_at: "2026-06-10T22:52:58.861547+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences amends bylaws; grants stock options to CEO, CSO, CFO

## Summary
- Reduced stockholder meeting quorum to one-third of voting power via new Second Amended and Restated Bylaws effective Sept 4, 2023.
- Approved incentive stock options for CEO James Woody (75k shares), CSO Jonathan Rothbard (15k), CFO Ozan Pamir (15k) at $0.67/share, vesting monthly over 12 months.
- Options granted under First Amended and Restated 2022 Omnibus Incentive Plan, with 10-year term.
- Bylaws also updated for SEC Rule 14a-19 proxy rules and exclusive means for stockholder proposals.

## SEC filing metadata
- accession: 0001213900-23-074568
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2023-09-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390023074568/0001213900-23-074568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390023074568/ea184802-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-074568
- JSON: https://secwatch.observer/filing/0001213900-23-074568.json
- Plain text: https://secwatch.observer/filing/0001213900-23-074568.txt

## Key facts
- Governance Changes
  FORUM MARKETS Inc: On September 4, 2023, the Board adopted Second Amended and Restated Bylaws making multiple changes including reducing quorum to one-third of voting power, removing stockholder list posting requirement, updating proxy rules per SEC Rule 14a-19, clarifying procedures for adjourned meetings and stockho (effective 2023-09-04).
  - Change: bylaw amendment
  - Effective: 2023-09-04
  source text: On September 4, 2023, the Board of Directors (the “ Board ”) of 180 Life Sciences Corp. (the “ Company ”), approved and adopted Second Amended and Restated Bylaws (the “ Second Amended and Restated Bylaws ”), which became effective the same day. The Second Amended and Restated Bylaws amend the prior bylaws of the Company to, among other things (a) reduce the number of shares required to constitute a quorum at a stockholders meeting of the holders of shares of outstanding capital stock of the Company to provide that stockholders holding one-third of the voting power of all outstanding shares of capital stock of the Company entitled to vote at such meeting shall constitute a quorum (Section 2.4); (b) remove the requirement to post the list of stockholders of the Company at meetings of stockholders (consistent with certain recent Delaware General Corporation Law rule changes)(Section 2.5(a)); (c) update the bylaws to address certain recent Securities and Exchange Commission rule changes i
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390023074568/0001213900-23-074568-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.